Humanities
Skip to main content Skip to main navigation menu Skip to site footer
  • Register
  • Login
  • Menu
  • Home
  • Current
  • Archives
  • Announcements
  • About
    • About the Journal
    • Submissions
    • Editorial Team
    • Privacy Statement
    • Contact
  • Register
  • Login

Journal of Education, Health and Sport

The world's first malaria vaccine – promising clinical results
  • Home
  • /
  • The world's first malaria vaccine – promising clinical results
  1. Home /
  2. Archives /
  3. Vol. 9 No. 8 (2019) /
  4. Review Articles

The world's first malaria vaccine – promising clinical results

Authors

  • Iga Dudek Student Research Circle at the Department of Epidemiology and Clinical Research Methodology, Medical University of Lublin
  • Jakub Czarnota Student Research Circle at the Department of Epidemiology and Clinical Research Methodology, Medical University of Lublin
  • Danuta Hajduga Student Research Circle at the Department of Epidemiology and Clinical Research Methodology, Medical University of Lublin
  • Michał Dobrzyński Student Research Circle at the Department of Epidemiology and Clinical Research Methodology, Medical University of Lublin
  • Magdalena Marzęda Student Research Circle at the Department of Epidemiology and Clinical Research Methodology, Medical University of Lublin

Keywords

malaria, the MVIP programme, vaccine

Abstract

Work on the malaria vaccine has been going on since the early 20st century. The RTS,S/AS01 (Mosquirix) vaccine is the first and only in the world that has shown action against Plasmodium falciparum, a germ that contributes to the highest number of deaths from malaria. After passing the three phases of clinical tests positively, the fourth phase was launched in 2019 - the MVIP program (The Malaria Vaccine Implementation Program). It covers three African countries: Kenya, Ghana and Modawi. Around 360,000 children are expected to receive the vaccine from these countries annually. The third phase of Mosquirix vaccine testing lasted five years (2009-2014) and was based on the extraction of 15 459 children and infants from seven African countries, followed by the administration of four doses of each medicine. In four years, among children aged 5-17 months who received 4 doses of Mosquirix, 4 out of 10 (39%) managed to prevent the development of malaria. The number of hospitalizations for malaria and severe anemia, which is one of the consequences of this disease, has also decreased significantly. In the fourth phase of the study, the role of the vaccine in reducing the number of deaths in children and its safety will be assessed in the context of routine, global use. Data from the MVIP program will include WHO recommendations on the wider use of the vaccine.

Downloads

  • PDF

Published

2019-09-14

How to Cite

1.
DUDEK, Iga, CZARNOTA, Jakub, HAJDUGA, Danuta, DOBRZYŃSKI, Michał and MARZĘDA, Magdalena. The world’s first malaria vaccine – promising clinical results. Journal of Education, Health and Sport. Online. 14 September 2019. Vol. 9, no. 8, pp. 912-919. [Accessed 17 May 2025].
  • ISO 690
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
Download Citation
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

Issue

Vol. 9 No. 8 (2019)

Section

Review Articles

License

The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0

Stats

Number of views and downloads: 240
Number of citations: 0

Search

Search

Browse

  • Browse Author Index
  • Issue archive

User

User

Current Issue

  • Atom logo
  • RSS2 logo
  • RSS1 logo

Information

  • For Readers
  • For Authors
  • For Librarians

Newsletter

Subscribe Unsubscribe

Tags

Search using one of provided tags:

malaria, the MVIP programme, vaccine
Up

Akademicka Platforma Czasopism

Najlepsze czasopisma naukowe i akademickie w jednym miejscu

apcz.umk.pl

Partners

  • Akademia Ignatianum w Krakowie
  • Akademickie Towarzystwo Andragogiczne
  • Fundacja Copernicus na rzecz Rozwoju Badań Naukowych
  • Instytut Historii im. Tadeusza Manteuffla Polskiej Akademii Nauk
  • Instytut Kultur Śródziemnomorskich i Orientalnych PAN
  • Instytut Tomistyczny
  • Karmelitański Instytut Duchowości w Krakowie
  • Ministerstwo Kultury i Dziedzictwa Narodowego
  • Państwowa Akademia Nauk Stosowanych w Krośnie
  • Państwowa Akademia Nauk Stosowanych we Włocławku
  • Państwowa Wyższa Szkoła Zawodowa im. Stanisława Pigonia w Krośnie
  • Polska Fundacja Przemysłu Kosmicznego
  • Polskie Towarzystwo Ekonomiczne
  • Polskie Towarzystwo Ludoznawcze
  • Towarzystwo Miłośników Torunia
  • Towarzystwo Naukowe w Toruniu
  • Uniwersytet im. Adama Mickiewicza w Poznaniu
  • Uniwersytet Komisji Edukacji Narodowej w Krakowie
  • Uniwersytet Mikołaja Kopernika
  • Uniwersytet w Białymstoku
  • Uniwersytet Warszawski
  • Wojewódzka Biblioteka Publiczna - Książnica Kopernikańska
  • Wyższe Seminarium Duchowne w Pelplinie / Wydawnictwo Diecezjalne „Bernardinum" w Pelplinie

© 2021- Nicolaus Copernicus University Accessibility statement Shop